There's more than one valid path — but the same key decision points
Getting access to a GLP-1 medication isn't a single linear process for everyone, but most paths run through the same core decision points: who evaluates and prescribes it, whether your insurance covers it, and how you ultimately source and fill the prescription. This guide walks through that workflow step by step.
The workflow at a glance
START: Considering a GLP-1 medication
|
v
STEP 1: Talk to your primary care provider (PCP)
|
v
Does your PCP prescribe GLP-1s directly?
/ \
YES NO
| |
v v
PCP evaluates you and Referral to a weight
starts the prescribing management / obesity
process directly medicine specialist
| |
| v
| Specialist evaluates you
| and starts the prescribing
| process
| |
\______________________________/
|
v
STEP 2: Verify your insurance coverage
- Check formulary status & cost tier
- Confirm prior authorization / step therapy rules
- Confirm diagnosis code (diabetes vs. weight mgmt)
|
v
Is it covered at an affordable cost?
/ \
YES NO
| |
v v
STEP 3a: Fill via a STEP 3b: Explore other
retail or specialty access paths:
pharmacy with your - Manufacturer savings
prescription (LillyDirect / NovoCare)
| - Patient assistance program
| - Compounded medication via
| a licensed telehealth
| provider or pharmacy
| - Appeal the denial
\___________________/
|
v
STEP 4: Decide — branded pen or compounded medication?
(see comparison below)
|
v
STEP 5: Begin titration under your prescriber's guidance
Step 1: Start with primary care — and expect a possible referral
Most people's first conversation about a GLP-1 medication happens with their primary care provider (PCP). See our discussion guide on talking to your doctor about GLP-1 medications for how to prepare for that appointment. From there, one of two things typically happens:
- Your PCP evaluates and prescribes directly. Many primary care providers are comfortable prescribing GLP-1 medications themselves, particularly for patients with type 2 diabetes or straightforward weight-management cases.
- Your PCP refers you to a weight management or obesity medicine specialist. This is common when your case involves more complex medical history, when your PCP prefers a specialist to manage titration and side effects, or simply based on your PCP's own practice patterns and comfort level with these medications. A specialist referral isn't a sign that something is wrong — it's a normal part of the process for many patients, and specialists are often more experienced with the full range of GLP-1 medications and dosing nuances.
Either path leads to the same next step: an actual evaluation (medical history, BMI, relevant comorbidities) and, if appropriate, a prescription.
Step 2: Verify your insurance coverage before assuming cost
Once you have — or are close to having — a prescription, check your coverage before you're standing at the pharmacy counter. See our detailed guide on how to determine if your formulary covers GLP-1 medications and our broader guide on understanding insurance coverage for GLP-1 medications for the full process, including formulary tiers, prior authorization, step therapy, and why your diagnosis code (diabetes vs. weight management) matters more than most people expect.
Step 3: If coverage falls short, you have real options
A denial or unaffordable cost isn't necessarily the end of the road:
- Manufacturer savings programs — see our glossary entries on LillyDirect and NovoCare
- Patient assistance programs for uninsured or underinsured patients — see our glossary entry on patient assistance programs
- Appealing a denial — see our guide on what a successful insurance appeal campaign looks like and how to write an effective appeal letter
- Compounded medication through a licensed telehealth provider or pharmacy — a common path when brand-name coverage isn't available or affordable, covered in more detail below
Step 4: Branded pen vs. compounded medication — how to decide
This is one of the more consequential decisions in the process, and it's worth making deliberately rather than defaulting to whichever option appears first in an ad or search result.
| Branded medication | Compounded medication | |
|---|---|---|
| Regulatory status | FDA-approved, standardized manufacturing | Not FDA-approved as a standalone product; legality tied to shortage status and pharmacy licensing — see our glossary entry on compounded semaglutide |
| Dosing device | Pre-set or dial pen — see our guide on pen types and injection technique | Often vial and syringe, requiring self-measured doses — see our guide on compounded dosing |
| Cost | Often higher list price, but potentially offset by insurance or manufacturer savings programs | Often lower out-of-pocket cost, particularly without insurance |
| Quality assurance | Manufacturer-standardized concentration and purity | Varies by pharmacy — verify GMP compliance and licensing directly; see our guide on talking to a pharmacist about compounded medications |
| How you access it | Prescriber + retail/specialty pharmacy | Often via telehealth platforms partnered with a compounding pharmacy |
| Key risk to manage | Cost and insurance navigation | Sourcing legitimacy — see our guide on the compounding pharmacy debate and glossary entry on the grey market |
If you're considering the telehealth-plus-compounded-medication path, the most important question to answer is whether the specific telehealth provider and pharmacy are legitimate and licensed — not just whether the price looks appealing. See our related guide on talking to a pharmacist about compounded medications and sourcing for the specific questions worth asking before committing to a source.
Step 5: Starting treatment
Once you have a prescription and a source, treatment begins with titration — see our guide on how titration schedules work for what to expect in the first weeks and months.
The bottom line
Getting access to a GLP-1 medication typically runs through the same sequence — a primary care or specialist evaluation, an insurance coverage check, and a deliberate decision about branded versus compounded sourcing if cost or coverage is a barrier. Treating each step as a distinct, deliberate decision — rather than defaulting to whatever's fastest — gives you the most control over cost, safety, and fit with your specific situation.